BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND MDM2, HDM2, 4193, ENSG00000135679, HDMX, MGC71221, hdm2, Q00987
337 results:

  • 1. PELI1: key players in the oncogenic characteristics of pancreatic cancer.
    Fei X; Zhu C; Liu P; Liu S; Ren L; Lu R; Hou J; Gao Y; Wang X; Pan Y
    J Exp Clin Cancer Res; 2024 Mar; 43(1):91. PubMed ID: 38528516
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Evolution of Testicular Germ Cell Tumors in the Molecular Era With Histogenetic Implications.
    Kilic I; Acosta AM; Idrees MT
    Adv Anat Pathol; 2024 May; 31(3):206-214. PubMed ID: 38525515
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Regulatory and Interacting Partners of PDLIM7 in Thyroid cancer.
    Rood K; Yamauchi CR; Sharma U; Laxa RT; Robins C; Lanza G; Sánchez-Ruiz K; Khan A; Kim HS; Shields A; Kennedy K; Mirshahidi S; Perez MC; Firek A; Munir I; Simental AA; Khan S
    Curr Oncol; 2023 Dec; 30(12):10450-10462. PubMed ID: 38132395
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Targeted inhibition of the ATR/CHK1 pathway overcomes resistance to olaparib and dysregulates DNA damage response protein expression in BRCA2
    Biegała Ł; Gajek A; Szymczak-Pajor I; Marczak A; Śliwińska A; Rogalska A
    Sci Rep; 2023 Dec; 13(1):22659. PubMed ID: 38114660
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Paratesticular Dedifferentiated Liposarcoma with Rhabdomyoblastic Differentiation: A Case Report and Review of the Literature.
    Keles A; Arikan O; Keser F; Yildirim ANT; Yildirim A
    Prague Med Rep; 2023; 124(4):449-455. PubMed ID: 38069650
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clinicopathologic Analysis and Molecular Profiling of Ovarian Steroid Cell Tumors.
    Mendoza RP; Wang P; Smith HL; Fitzpatrick CA; Haridas R; Wanjari P; Briese R; Shahid A; McCluggage WG; Bennett JA
    Am J Surg Pathol; 2023 Dec; 47(12):1398-1408. PubMed ID: 37796179
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Synthesis, characterization, and biological properties of novel Schiff bases containing pentafluorophenyl hydrazine.
    Hamurcu F
    J Biochem Mol Toxicol; 2023 Dec; 37(12):e23512. PubMed ID: 37638565
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Identification of mdm2 as a prognostic and immunotherapeutic biomarker in a comprehensive pan-cancer analysis: A promising target for breast cancer, bladder cancer and ovarian cancer immunotherapy.
    Zheng J; Miao F; Wang Z; Ma Y; Lin Z; Chen Y; Kong X; Wang Y; Zhuang A; Wu T; Li W
    Life Sci; 2023 Aug; 327():121832. PubMed ID: 37276911
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Molecular and Functional Heterogeneity of Primary Pancreatic Neuroendocrine Tumors and Metastases.
    Guo Y; Tian C; Cheng Z; Chen R; Li Y; Su F; Shi Y; Tan H
    Neuroendocrinology; 2023; 113(9):943-956. PubMed ID: 37232011
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Optimized spirooxindole-pyrazole hybrids targeting the p53-mdm2 interplay induce apoptosis and synergize with doxorubicin in A549 cells.
    Islam MS; Al-Majid AM; Sholkamy EN; Barakat A; Viale M; Menichini P; Speciale A; Loiacono F; Azam M; Verma VP; Yousuf S; Teleb M
    Sci Rep; 2023 May; 13(1):7441. PubMed ID: 37156796
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Treatment for ovarian clear cell carcinoma with combined inhibition of WEE1 and ATR.
    Chien W; Tyner JW; Gery S; Zheng Y; Li LY; Gopinatha Pillai MS; Nam C; Bhowmick NA; Lin DC; Koeffler HP
    J Ovarian Res; 2023 Apr; 16(1):80. PubMed ID: 37087441
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Molecular Correlates of Aggressive Behavior and Biological Progression in Testicular Sertoli Cell Tumors.
    Rizzo NM; Sholl LM; Kao CS; Cornejo KM; Sangoi AR; Hirsch MS; Collins K; Gordetsky JB; Reyes Curcio FA; Fletcher CDM; Ulbright TM; Acosta AM
    Mod Pathol; 2023 Jul; 36(7):100152. PubMed ID: 36906070
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Expression and Clinical Significance of mdm2 in Non-Functioning PitNETs.
    Yao X; Liu Q; Zhao S; Cheng R; Liu C; Zhang G
    Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837574
    [No Abstract]    [Full Text] [Related]  

  • 14. Drug response profiles in patient-derived cancer cells across histological subtypes of ovarian cancer: real-time therapy tailoring for a patient with low-grade serous carcinoma.
    Murumägi A; Ungureanu D; Khan S; Arjama M; Välimäki K; Ianevski A; Ianevski P; Bergström R; Dini A; Kanerva A; Koivisto-Korander R; Tapper J; Lassus H; Loukovaara M; Mägi A; Hirasawa A; Aoki D; Pietiäinen V; Pellinen T; Bützow R; Aittokallio T; Kallioniemi O
    Br J Cancer; 2023 Feb; 128(4):678-690. PubMed ID: 36476658
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The risk of cancer in patients with primary Sjögren syndrome: a single-center study from Turkey.
    Aslan B; Öğüt TS; Erbasan F; Dilbil M; Çelik E; Terzioğlu ME; Yazısız V
    Turk J Med Sci; 2022 Jun; 52(3):587-595. PubMed ID: 36326315
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Molecular correlates of male germ cell tumors with overgrowth of components resembling somatic malignancies.
    Wyvekens N; Sholl LM; Yang Y; Tran I; Vasudevaraja V; Dickson BC; Al-Obaidy KI; Baniak N; Collins K; Gordetsky JB; Idrees MT; Kao CS; Maclean F; Matoso A; Ulbright TM; Wobker SE; Fletcher CDM; Hirsch MS; Hornick JL; Snuderl M; Acosta AM
    Mod Pathol; 2022 Dec; 35(12):1966-1973. PubMed ID: 36030288
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Mechanism of apoptosis activation by Curcumin rescued mutant p53Y220C in human pancreatic cancer.
    Malhotra L; Sharma S; Hariprasad G; Dhingra R; Mishra V; Sharma RS; Kaur P; Ethayathulla AS
    Biochim Biophys Acta Mol Cell Res; 2022 Dec; 1869(12):119343. PubMed ID: 36007676
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. p53 as a unique target of action of cisplatin in acute leukaemia cells.
    Kumar S; Tchounwou PB
    J Cell Mol Med; 2022 Sep; 26(17):4727-4739. PubMed ID: 35946055
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Enhancement of mdm2 inhibitory effects through blocking nuclear export mechanisms in ovarian cancer cells.
    Alzahrani A; Natarajan U; Rathinavelu A
    Cancer Genet; 2022 Aug; 266-267():57-68. PubMed ID: 35785714
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Survivin, sonic hedgehog, krüppel-like factors, and p53 pathway in serous ovarian cancer: an immunohistochemical study.
    Londero AP; Orsaria M; Viola L; Marzinotto S; Bertozzi S; Galvano E; Andreetta C; Mariuzzi L
    Hum Pathol; 2022 Sep; 127():92-101. PubMed ID: 35777700
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 17.